Skip to content

The Intertransverse Process Block - Single or Multiple Injection? A randomised, procedure related, blinded crossover trial in healthy volunteers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-501312-34-01
Acronym
ZUH-ITP-MBCS
Enrollment
12
Registered
2023-01-24
Start date
2023-02-26
Completion date
2023-03-08
Last updated
2023-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The ITP block is primarily used for pain amelioration after breast cancer surgery.

Brief summary

The primary outcome of this procedure related study is the number of anaesthetised thoracic dermatomes

Detailed description

“Sensory mapping”: the extent of cutaneous spread of the sensory block (area in cm2), To evaluate thermography in a clinical setup (the temperature differences between non-blockade side and blockade side), To evaluate changes in non-invasive blood pressure, To evaluate block application satisfaction in numeric rating scale pain scores

Interventions

DRUGALFENTANIL
DRUGlösning

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The primary outcome of this procedure related study is the number of anaesthetised thoracic dermatomes

Secondary

MeasureTime frame
“Sensory mapping”: the extent of cutaneous spread of the sensory block (area in cm2), To evaluate thermography in a clinical setup (the temperature differences between non-blockade side and blockade side), To evaluate changes in non-invasive blood pressure, To evaluate block application satisfaction in numeric rating scale pain scores

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 6, 2026